Alliqua (ALQA) Tops Q3 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Alliqua BioMedical, Inc. Reports Third Quarter Financial Results
November 5, 2015 7:01 AM ESTLANGHORNE, Pa., Nov. 5, 2015 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq: ALQA) ("Alliqua" or "the Company"), a provider of advanced wound care products, today announced financial results for the third quarter ended September 30, 2015.
Q3 Highlights:
Total revenue increased 236% year-over-year to $5.0 million. Organic revenue growth was approximately 52% year-over-year. Products revenue increased 354% year-over-year to $4.5 million, of which organic product revenue growth was 78% year-over-year. Gross margin was 67%, compared to 39% last year and 56% in the second quarter of 2015. Product margin revenue was approximately 80% in the quarter. On September 24th, Alliqua... More